Loading clinical trials...
Loading clinical trials...
Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma.
Conditions
Interventions
dermo-cosmetic product
Start Date
July 1, 2024
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
May 17, 2024
NCT07236021
NCT05932680
NCT04236063
NCT04364724
NCT03607643
Lead Sponsor
Nantes University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions